Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Eptacog Alfa in Severe Postpartum Haemorrhage in India: A Phase IV Interventional Study

NCT07157423 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07157423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07157423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Eptacog Alfa in Severe Postpartum Haemorrhage in India: A Phase IV Interventional Study
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Recruiting
Start date
August 26, 2025
Completion date
August 26, 2027
Enrollment
64 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

severe postpartum haemorrhage